Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Documenti analoghi

• ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high ( MSI ‐H) molecular subtype
  di: Melica Nourmoussavi Brodeur, et al.
  Pubblicazione: (2024)
• Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
  di: Ying L. Liu, et al.
  Pubblicazione: (2025)
• Fused filament fabrication using stainless steel 316L‐polymer blend: Analysis and optimization for green density and surface roughness
  di: Habika O'Connor, et al.
  Pubblicazione: (2024)
• A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair‐deficient and microsatellite instability‐high endometrial cancers
  di: Ying L. Liu, et al.
  Pubblicazione: (2024)
• Reflexive homology
  di: Graves, Daniel
  Pubblicazione: (2022)